GAMMA Investing’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.45M Buy
8,872
+279
+3% +$134K 0.17% 90
2026
Q1
$4.22M Buy
8,593
+1,559
+22% +$846K 0.2% 76
2025
Q4
$4.08M Buy
7,034
+1,364
+24% +$771K 0.2% 73
2025
Q3
$2.75M Buy
5,670
+1,570
+38% +$731K 0.15% 100
2025
Q2
$1.66M Sell
4,100
-762
-16% -$319K 0.11% 167
2025
Q1
$2.42M Buy
4,862
+877
+22% +$475K 0.18% 95
2024
Q4
$2.07M Sell
3,985
-866
-18% -$476K 0.18% 99
2024
Q3
$3M Buy
4,851
+1,115
+30% +$660K 0.3% 49
2024
Q2
$2.07M Buy
3,736
+807
+28% +$462K 0.28% 53
2024
Q1
$1.7M Buy
2,929
+539
+23% +$302K 0.35% 43
2023
Q4
$1.29M Buy
+2,390
New +$1.16M 0.35% 43

Other funds holding TMO

GAMMA Investing's TMO Position: Q2 2026 in Review

GAMMA Investing increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q2 2026, buying an estimated $134K and bringing the position to 8,872 shares worth $4.45M. The position accounts for 0.17% of the portfolio, ranked #90.

GAMMA Investing first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • GAMMA Investing held 8,872 shares of Thermo Fisher Scientific worth $4.45M as of Q2 2026.
  • GAMMA Investing bought 279 Thermo Fisher Scientific shares in Q2 2026, an estimated $134K.
  • Thermo Fisher Scientific made up 0.17% of GAMMA Investing's portfolio in Q2 2026, its #90 holding.
  • GAMMA Investing first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.